Understanding the validity of self-reported positive family history of lymphoma in extended families to facilitate genetic epidemiology and clinical practice

References

• Berberich F R, Berberich M S, King M C, Engleman E G, Grumet F C. Hodgkin's disease susceptibility: linkage to the HLA locus demonstrated by a new concordance method. Hum Immunol 1983; 6: 207–217
   PubMed Web of Science ®Google Scholar
• Goldin L R, Pfeiffer R M, Gridley G, Gail M H, Li X, Mellemkjaer L, et al. Familial aggregation of Hodgkin lymphoma and related tumors. Cancer 2004; 100: 1902–1908
   PubMed Web of Science ®Google Scholar
• Mack T M, Cozen W, Shibata D K, Weiss L M, Nathwani B N, Hernandez A M, et al. Concordance for Hodgkin's disease in identical twins suggesting genetic susceptibility to the young-adult form of the disease. N Engl J Med 1995; 332: 413–418
   PubMed Web of Science ®Google Scholar
• Hemminki K, Czene K. Attributable risks of familial cancer from the Family-Cancer Database. Cancer Epidemiol Biomarkers Prev 2002; 11: 1638–1644
   PubMed Web of Science ®Google Scholar
• John E M, Hopper J L, Beck J C, Knight J A, Neuhausen S L, Senie R T, et al. The Breast Cancer Family Registry (Breast CFR): an infrastructure for cooperative multinational, interdisciplinary and translational studies of the genetic epidemiology of breast cancer. Breast Cancer Res 2004; 6: R375–R389
   PubMed Web of Science ®Google Scholar
• Verkooijen H M, Fioretta G, Chappuis P O, Vlastos G, Sappino A P, Benhamou S, et al. Set-up of a population-based familial breast cancer registry in Geneva, Switzerland: validation of first results. Ann Oncol 2004; 15: 350–353
   PubMed Web of Science ®Google Scholar
• Ziogas A, Anton-Culver H. Validation of family history data in cancer family registries. Am J Prev Med 2003; 24: 190–198
   PubMed Web of Science ®Google Scholar
• Casey G, Lindor N M, Papadopoulos N, Thibodeau S N, Moskow J, Steelman S, et al. Conversion analysis for mutation detection in MLH1 and MSH2 in patients with colorectal cancer. JAMA 2005; 293: 799–809
   PubMed Web of Science ®Google Scholar
• Murff H J, Spigel D R, Syngal S. Does this patient have a family history of cancer? An evidence-based analysis of the accuracy of family cancer history. JAMA 2004; 292: 1480–1489
   PubMed Web of Science ®Google Scholar
• Chang E T, Smedby K E, Hjalgrim H, Glimelius B, Adami H O. Reliability of self-reported family history of cancer in a large case-control study of lymphoma. J Natl Cancer Inst 2006; 98: 61–68
   PubMed Web of Science ®Google Scholar
• H D Ries Lag, Krapcho, M, Mariotto, A, Miller, B A, Feuer, E J, Clegg, L, Eisner, M P. SEER Cancer Statistics Review, 1975 – 2003. Bethesda, MD, National Cancer Institute. 2006, Available at http://seer.cancer.gov/csr/1975_2003/.
   Google Scholar
• Aitken J, Bain C, Ward M, Siskind V, MacLennan R. How accurate is self-reported family history of colorectal cancer?. Am J Epidemiol 1995; 141: 863–871
   PubMed Web of Science ®Google Scholar
• Kerber R A, Slattery M L. Comparison of self-reported and database-linked family history of cancer data in a case-control study. Am J Epidemiol 1997; 146: 244–248
   PubMed Web of Science ®Google Scholar
• Glaser S L, Clarke C A, Nugent R A, Stearns C B, Dorfman R F. Reproductive risk factors in Hodgkin's disease in women. Am J Epidemiol 2003; 158: 553–563
   PubMed Web of Science ®Google Scholar
• Glaser S L, Stearns C B. Reliability of random-digit dialing screening calls to enumerate an adult female population. Am J Epidemiol 2002; 155: 972–975
   PubMed Web of Science ®Google Scholar
• Hors J, Dausset J. HLA and susceptibility to Hodgkin's disease. Immunol Rev 1983; 70: 167–192
   PubMed Web of Science ®Google Scholar
• Lynch H T, Saldivar V A, Guirgis H A, Terasaki P I, Bardawil W A, Harris R E, et al. Familial Hodgkin's disease and associated cancer. Cancer 1976; 38: 2033–2041
   PubMed Web of Science ®Google Scholar
• Glaser S L, Clarke C A, Nugent R A, Stearns C B, Dorfman R F. Social class and risk of Hodgkin's disease in young-adult women in 1988 – 94. Int J Cancer 2002; 98: 110–117
   PubMed Web of Science ®Google Scholar
• Mueller N, Grufferman S. The epidemiology of Hodgkin's disease. Hodgkin's Disease, P M Mauch, J O Armitage, V Diehl, R T Hoppe, L M Weiss. Lippincott Williams & Wilkins, Philadelphia 1999; 61–77
   Google Scholar
• Georgii A, Fischer R, Hubner K, Schwarze E W, Bernhards J. Classification of Hodgkin's disease biopsies by a panel of four histopathologists. Report of 1140 patients from the German National Trial. Leuk Lymphoma 1993; 9: 365–370
   PubMed Web of Science ®Google Scholar
• Glaser S L, Dorfman R F, Clarke C A. Expert review of the diagnosis and histologic classification of Hodgkin's disease in a population-based cancer registry: interobserver reliability and impact on incidence and survival rates. Cancer 2001; 92: 218–224
   PubMed Web of Science ®Google Scholar
• Holman C DJ, Matz L R, Finlay-Jones L R, Waters E D, Blackwell J B, Joyce P R, et al. Inter-observer variation in the histopathological reporting of Hodgkin's disease: an analysis of diagnostic subcomponents using kappa statistics. Histopathol 1983; 7: 399–407
   PubMed Web of Science ®Google Scholar
• Airewele G, Adatto P, Cunningham J, Mastromarino C, Spencer C, Sharp M, et al. Family history of cancer in patients with glioma: a validation study of accuracy. J Natl Cancer Inst 1998; 90: 543–544
   PubMed Web of Science ®Google Scholar
• Novakovic B, Goldstein A M, Tucker M A. Validation of family history of cancer in deceased family members. J Natl Cancer Inst 1996; 88: 1492–1493
   PubMed Web of Science ®Google Scholar
• Hemminki K, Li X, Czene K. Familial risk of cancer: data for clinical counseling and cancer genetics. Int J Cancer 2004; 108: 109–114
   PubMed Web of Science ®Google Scholar
• Zippin C, Lum D, Hankey B F. Completeness of hospital cancer case reporting from the SEER Program of the National Cancer Institute. Cancer 1995; 76: 2343–2350
   PubMed Web of Science ®Google Scholar
• Percy C, Stanek E, Gloeckler L. Accuracy of cancer death certificates and its effect on cancer mortality statistics. Am J Public Health 1981; 71: 242–250
   PubMed Web of Science ®Google Scholar
• Bondy M L, Strom S S, Colopy M W, Brown B W, Strong L C. Accuracy of family history of cancer obtained through interviews with relatives of patients with childhood sarcoma. J Clin Epidemiol 1994; 47: 89–96
   PubMed Web of Science ®Google Scholar
• Tepper A, Connally L B, Haltmeier P, Smith E, Sweeney M H. Knowledge of medical history information among proxy respondents for deceased study subjects. J Clin Epidemiol 1993; 46: 1243–1248
   PubMed Web of Science ®Google Scholar
• Love R R, Evans A M, Josten D M. The accuracy of patient reports of a family history of cancer. J Chronic Dis 1985; 38: 289–293
   PubMedGoogle Scholar
• Goldin L R, McMaster M L, Ter-Minassian M, Saddlemire S, Harmsen B, et al. A genome screen of families at high risk for Hodgkin lymphoma: evidence for a susceptibility gene on chromosome 4. J Med Genet 2005; 42: 595–601
   PubMed Web of Science ®Google Scholar
• Kanzler H, Kuppers R, Hansmann M L, Rajewsky K. Hodgkin and Reed-Sternberg cells in Hodgkin's disease represent the outgrowth of a dominant tumor clone derived from (crippled) germinal center B cells. J Exp Med 1996; 184: 1495–1505
   PubMed Web of Science ®Google Scholar
• Rosenwald A, Wright G, Leroy K, Yu X, Gaulard P, Gascoyne R D, et al. Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphoma. J Exp Med 2003; 198: 851–862
   PubMed Web of Science ®Google Scholar
• Savage K J, Monti S, Kutok J L, Cattoretti G, Neuberg D, De Leval L, et al. The molecular signature of mediastinal large B-cell lymphoma differs from that of other diffuse large B-cell lymphomas and shares features with classical Hodgkin lymphoma. Blood 2003; 102: 3871–3879
   PubMed Web of Science ®Google Scholar
• Schmitz R, Renne C, Rosenquist R, Tinguely M, Distler V, Menestrina F, et al. Insights into the multistep transformation process of lymphomas: IgH-associated translocations and tumor suppressor gene mutations in clonally related composite Hodgkin's and non-Hodgkin's lymphomas. Leukemia 2005; 19: 1452–1458
   PubMed Web of Science ®Google Scholar